<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Interactive diabetes case 15: A 74-year-old patient with type 2 diabetes and recurrent hyperkalemia – C3
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Interactive diabetes case 15: A 74-year-old patient with type 2 diabetes and recurrent hyperkalemia – C3
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Interactive diabetes case 15: A 74-year-old patient with type 2 diabetes and recurrent hyperkalemia – C3
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Lloyd Axelrod, MD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Jan 22, 2024.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          ANSWER
         </span>
         <span class="headingEndMark">
          —
         </span>
         Incorrect.
        </p>
        <p>
         Increases in the doses of insulin are necessary for the management of the patient's uncontrolled diabetes but not sufficient at this time to produce a meaningful decrease in the serum potassium level.
        </p>
        <p>
         The patient needs additional therapy to break the pattern of recurrent hyperkalemia, which can no longer be attributed to hyperglycemia-induced hyperkalemia, to medications, or to impaired kidney function at the current levels of serum creatinine.
        </p>
        <p>
         The patient now has the typical profile of a patient with hyporeninemic hypoaldosteronism (type 4 renal tubular acidosis [RTA]): over 50 years of age with diabetic nephropathy and mild to moderate impaired kidney function. The blood glucose levels are not sufficiently elevated to explain the hyperkalemia, she is no longer on medications that cause hyperkalemia, and she is following a low potassium diet. It is time to initiate
         <a class="drug drug_general" data-topicid="8455" href="/z/d/drug information/8455.html" rel="external">
          fludrocortisone
         </a>
         .
        </p>
        <p>
         The diagnosis of Addison's disease should always be considered in the evaluation of a patient with hyperkalemia. However, in the present patient, the prior probability before further evaluation and treatment strongly favors the diagnosis of hyporeninemic hypoaldosteronism (type 4 RTA) for the reasons noted above. In addition, she has type 2 diabetes with no evidence of any autoimmune disease. Also, the serum sodium level has been persistently normal and the blood pressure is elevated despite treatment with a thiazide diuretic, both of which reduce the probability of Addison's disease, a rare disorder. It is reasonable to initiate a trial of therapy with
         <a class="drug drug_general" data-topicid="8455" href="/z/d/drug information/8455.html" rel="external">
          fludrocortisone
         </a>
         .
        </p>
        <p>
         Return to the previous choice to try again. (See
         <a class="medical medical_answer" href="/z/d/html/4239.html" rel="external">
          "Interactive diabetes case 15: A 74-year-old patient with type 2 diabetes and recurrent hyperkalemia – B3"
         </a>
         .)
        </p>
       </div>
       <div id="topicVersionRevision">
        Topic 4242 Version 6.0
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
